BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...

HOLX is leaning into international growth with Surgical division strength and untapped demand driving momentum abroad.

BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector technology.

Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...

Key Points Medtronic is closing in on Dividend King status and has a historically high yield.Becton, Dickinson is already a Dividend King and has a relatively high yield.Universal Health has a huge ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor ...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...

A London court convicts four over a botched crypto wrench attack kidnapping, underscoring the dangers of "flex culture." ...

This was the stock's second consecutive day of losses.

Disney previously announced that the popular BDX droid characters would eventually come to Walt Disney World after making ...

Disney’s new BDX droids use AI and reinforcement learning to walk, emote, and interact — bringing characters to life faster ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...